US Market Changes in the Treatment of Advanced Prostate CancerThe Assessment GroupSeptember 20, 2012 30 Pages - SKU: TAG4931593 |
- Chapter 1: Introduction
- Chapter 2: Respondent Demographics
- Chapter 3: Treatment of a Patient with Increased PSA and Adenocarcinoma
- Chapter 4: Elderly Patient Treated for Gleason’s 7 Adenocarcinoma, Increased PSA 18 Months Later
- Chapter 5: Patient with Gleason’s 3+4 Adenocarcinoma and Multiple Metastases to Pelvis and Spine Develops Castration-resistant Disease
- Chapter 6: Elderly Patient with Gleason’s 5+5 and Multiple Metastases
- Appendix A: Survey Instrument
More Men's Health reports by The Assessment Group
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists' Survey by The Assessment Group
See all reports like this >>Progressively unfolding patient situation, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific ...
More United States Men's Health reports
Sperm Banks in the US - Industry Market Research Report by IBISWorld
Sperm Banks Moving upstream The Sperm Banks industry has performed strongly during the past five years, despite a marginal recessionary setback. Confidence in having children is on ...
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists' Survey by The Assessment Group
Progressively unfolding patient situation, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific ...
Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData's pharmaceutical report, “Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020” is ...
U.S. Benign Prostatic Hyperplasia Markets by Frost & Sullivan
See all reports like this >> Shifting Focus from Symptom Relief to Disease Management to treat Benign Prostatic Hyperplasia Increases the Treated Population Base There is tremendous potential for the U.S. ...
More United States reports
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by Mintel - Snapshots
See all reports like this >>Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
- Diseases & Conditions
- Cancer Treatment
- Pharmaceuticals
- Drug Discovery
- Therapeutic Area
- Oncology/Hematology
- Men's Health
Men's Health Reports
- Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides
- Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides
- Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
- Testicular Cancer Global Clinical Trials Review, H2, 2012
- Other Male Health Disorders – Pipeline Review, H2 2012
